Aditxt, Inc. (ADTX) currently reads Oversold on the MarketMoodz overbought/oversold meter, as of August 19, 2026. The Healthcare name (Biotechnology) last closed at $0.00. The rating moved from Strong Oversold to Oversold on August 19, 2026.

• Public ratingOversold (as of August 19, 2026)
• Last close$0.00
• Last changeMoved from Strong Oversold to Oversold on August 19, 2026
• SectorHealthcare
• IndustryBiotechnology

See all oversold Healthcare stocks →

AI analysis

Aditxt, Inc. shows characteristics of a highly speculative microcap with minimal public disclosure and very low liquidity. There are no company-specific filings or social sentiment signals in the provided data to support near-term upside, while standard microcap risks — dilution, trading suspension, wide spreads, and operational opacity — dominate the outlook. Absent clear financials, binding contracts, or regulatory/clinical catalysts disclosed, downside scenarios (capital raises, further share-price erosion, or delisting) are more probable than meaningful recovery within the next month.

Key factors

• Extremely low share price and microcap/OTC-like status with very thin liquidity and wide spreads
• No EDGAR filing comparisons or recent public financial disclosure referenced in the provided data
• High likelihood of equity dilution or dilutive financing given small market capitalization and funding needs
• Limited social-media and analyst coverage, reducing transparency and increasing information asymmetry
• Macro/sector themes provided do not point to company-specific near-term commercial catalysts
• Material operational and execution risk typical of sub-penny issuers (business continuity, revenue sustainability)

Risks

• Delisting, trading suspension, or removal from quotation systems
• Severe liquidity constraints and inability to exit positions at quoted prices
• Significant dilution from future financings or convertible securities issuance
• Insufficient or opaque financial reporting leading to investor uncertainty
• Regulatory, legal, or corporate-governance issues common among very small issuers
• Market manipulation or pump-and-dump activity increasing short-term volatility

Latest MarketMoodz coverage

• La-Z-Boy Jumps 20% Premarket After Q4 Beat and $300M Buyback2026-06-17

This page is for informational purposes only and is not investment, financial, tax, or legal advice. Ratings and research outputs can be wrong, incomplete, or stale. Past performance does not guarantee future results. Always do your own research and consider consulting a qualified professional.